Breastfeeding With Epilepsy Medication Proven Safe

New research shows anti-seizure medication use during breastfeeding does not negatively affect child neurodevelopment.

Updated on Sept. 30, 2026 in Babies

Gouache-painted illustration of a wooden block with a carved sprout icon resting on linen, representing peaceful maternal wellness.
A new U.S. study confirms that breastfeeding by mothers taking common anti-seizure medications has no negative impact on infant neurodevelopment by age six. AI Illustration. Upload story photo >

Live Poll

Do you feel confident following medical advice regarding breastfeeding while taking long-term prescription medications?

A recent study found that children born to women taking common anti-seizure medications showed no differences in language development compared to their peers by age six. These findings provide clarity for mothers with epilepsy who have previously avoided breastfeeding due to concerns over drug transfer.

Why it matters

Many women with epilepsy have traditionally avoided breastfeeding because of uncertainty regarding medication safety for infants. This study offers evidence that medication use does not hinder early childhood neurodevelopment, potentially changing how families manage infant nutrition.

Researchers monitored 202 women who initiated breastfeeding, with 125 continuing for at least six months. Children breastfed for six months or longer actually showed higher adaptive behavioral scores at age six.

The players

JAMA Network Open

A monthly open-access medical journal that publishes research relevant to clinical care and public health.

The details

The study tracked children born between 2012 and 2016 from 20 epilepsy centers across the U.S. Researchers evaluated participants taking medications like lamotrigine and levetiracetam, monitoring the infants until age six through verbal language and adaptive behavior assessments. The findings confirmed that the specific type of anti-seizure medication used had no measurable impact on a child's neurodevelopmental progress.

Timeline

  1. 2012-2016: Birth period for the study cohort.

  2. Age six: Children completed final neurodevelopmental assessments.

  3. September 2026: Study results published in JAMA Network Open.

The Home Front

This research shifts medical guidance for families managing chronic neurological conditions while navigating newborn care. It reinforces the importance of using evidence-based data to make decisions about infant feeding and medication management.

If you are managing epilepsy during pregnancy or postpartum, consult your neurologist or OB-GYN to review your specific medication plan. Use this new data as a starting point for a conversation with your care team about your family's feeding goals.

The takeaway

Breastfeeding for six months or longer may provide developmental benefits, even when the mother takes prescribed anti-seizure medication. Families should keep these findings in mind when planning their postpartum health and nutrition strategies with their primary care providers.

Further reading

For more on early infant care and health, browse our Babies section.

Source note: This article includes information reported by Nursing Times.

Live Poll

Do you feel confident following medical advice regarding breastfeeding while taking long-term prescription medications?